Immunohistochemistry demonstrated diffuse nuclear STAT6 and CD34 positivity, confirming SFT, with a low Ki-67 labeling index of 5%, and no necrosis or significant mitotic activity. This evidence concerns the gene MKI67 and solitary fibrous tumor.